Bruce Neal's Publications

About Bruce Neal's Publications

Executive Director, The George Institute for Global Health, Australia

  • Sodium-glucose co-transporter-2 inhibitors with and without metformin: A meta-analysis of cardiovascular, kidney and mortality outcomes

    Diabetes, Obesity and Metabolism Date published:

  • Sodium-glucose co-transporter-2 inhibition and ocular outcomes in patients with type 2 diabetes: A systematic review and meta-analysis

    Diabetes, Obesity and Metabolism Date published:

  • Mediators of the effects of canagliflozin on kidney protection in patients with type 2 diabetes

    Kidney International Date published:

  • Estimated 24-Hour Urinary Sodium Excretion and Incident Cardiovascular Disease and Mortality Among 398 628 Individuals in UK Biobank

    Hypertension Date published:

  • Prospective associations of the original Food Standards Agency nutrient profiling system and three variants with weight gain, overweight and obesity risk: results from the French NutriNet-Santé cohort

    British Journal of Nutrition Date published:

  • diabetologia

    Diabetologia Date published:

  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:

  • Prospective associations of four nutrient profiles with weigh gain, overweight and obesity risk

    European Journal of Public Health Date published:

  • Impact of salt substitute and stepwise reduction of salt supply on blood pressure in residents in senior residential facilities: Design and rationale of the DECIDE-Salt trial

    American Heart Journal Date published:

  • Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS Program

    Diabetes, Obesity and Metabolism Date published:

  • Rationale, design, and baseline characteristics of the Salt Substitute in India Study (SSiIS): The protocol for a double-blinded, randomized-controlled trial

    The Journal of Clinical Hypertension Date published:

  • Different eGFR Decline Thresholds and Renal Effects of Canagliflozin: Data from the CANVAS Program

    Journal of the American Society of Nephrology Date published:

  • The impact of 2019 novel coronavirus on heart injury: A Systematic review and Meta-analysis

    Progress in Cardiovascular Diseases Date published:

  • Effects of Allopurinol on the Progression of Chronic Kidney Disease

    New England Journal of Medicine Date published:

  • The effect of canagliflozin on amputation risk in the CANVAS program and the CREDENCE trial

    Diabetes, Obesity and Metabolism Date published:

  • Contribution of major food companies and their products to household dietary sodium purchases in Australia

    International Journal of Behavioral Nutrition and Physical Activity Date published: